The Eurolife symposium “A journey throught Neurosciences” (Tuesday, October 24, 2017 at 16:25h) brings at the University of Barcelona together Eurolife, the Institute of Neurosciences UB and their respective members, as well as students of the MSc in Neurosciences degree. The aim of the conference is to open a sustainable process of dialogue, to exchange knowledge and to increase cooperation between Eurolife institutions.
University of Barcelona
Ilse Boekhoud – PhD student at LUMC- shares her experience of attending the Eurolife Summer School 2017: From the 10th to the 14th of July, master- and PhD students had the opportunity to attend the first Eurolife summer school ìn 2017 entitled ‘Antimicrobial drug resistance – Research and Innovation’ at the University of Barcelona. The LUMC is participating in Eurolife and was represented in Barcelona by two teachers (dr. Peter Nibbering and prof. Ed Kuijper) and one PhD student (Ilse Boekhoud).
The Eurolife Summer School 2017 started on July 10 and continued until July 14. This first edition has been devoted to the Antimicrobial drug resistance field. All courses of the Summer School were taught in the Faculty of Medicine and Health Sciences of the University of Barcelona. The Eurolife Summer School provided doctoral and MSc […]
Antimicrobial resistance in pathogens is one of the biggest threats in the world. The amount of isolated bacteria that present resistance to drugs used to fight them has increased over the last decades. As a result, the number of active antimicrobial agents has reduced and the search for new approaches in this field has become […]
The “Antimicrobial drug resistance – Research and Innovation” Eurolife Summer School will be held in Barcelona (School of Medicine – University of Barcelona) from 10th-14th July 2017. This 5-days International Summer School is focused on the current challenges of antimicrobial resistance including: molecular bases of antimicrobial resistance, antimicrobial stewardship, strategies to control the emergence and spread of multidrug resistant bacteria in different settings, design of new rapid diagnostic tools, research for the development of new drugs, novel therapeutic and diagnostic strategies as well as interventions to tackle antimicrobial resistance.